Assyro AI

FDA Orange Book · active-ingredient family

Meloxicam; rizatriptan benzoate

Meloxicam; rizatriptan benzoate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:SYMBRAVO · NDA 215431

1

Brand (NDA)

0

Generics (ANDA)

94

Listed patents

1

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
SYMBRAVORLDAXSOMENDA 215431Jan 30, 2025

Marketing exclusivity (1)

  • NPNew product exclusivity (3 years)

    Jan 30, 2028

    in 1 yr 8 mo

Listed patents (94)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10702535Apr 11, 2036in 9 yr 11 mo
U-4136
10702602Apr 11, 2036in 9 yr 11 mo
U-1719
11013806Apr 11, 2036in 9 yr 11 mo
U-1719
10722583Apr 11, 2036in 9 yr 11 mo
U-1719
10987358Apr 11, 2036in 9 yr 11 mo
U-1719
10729696Apr 11, 2036in 9 yr 11 mo
U-1719
10688102Apr 11, 2036in 9 yr 11 mo
U-1719
11865117Apr 11, 2036in 9 yr 11 mo
U-1719
10729697Apr 11, 2036in 9 yr 11 mo
U-1719
11617755Apr 11, 2036in 9 yr 11 mo
U-1719
10729773Apr 11, 2036in 9 yr 11 mo
U-1719
10517950Apr 11, 2036in 9 yr 11 mo
U-1719
11426414Apr 11, 2036in 9 yr 11 mo
U-1719
9821075Apr 11, 2036in 9 yr 11 mo
ProductU-1719
10029010Apr 11, 2036in 9 yr 11 mo
U-4133
10137131Apr 11, 2036in 9 yr 11 mo
ProductU-1719
10195278Apr 11, 2036in 9 yr 11 mo
U-1719
10695429Apr 11, 2036in 9 yr 11 mo
U-1719
10265324Apr 11, 2036in 9 yr 11 mo
U-1719
11369684Apr 11, 2036in 9 yr 11 mo
U-1719
10695430Apr 11, 2036in 9 yr 11 mo
U-1719
10363312Apr 11, 2036in 9 yr 11 mo
U-1719
10688185Apr 11, 2036in 9 yr 11 mo
U-1719
10653777Apr 11, 2036in 9 yr 11 mo
U-1719
10583144Apr 11, 2036in 9 yr 11 mo
U-1719
11331323Apr 11, 2036in 9 yr 11 mo
U-1719
10561664Apr 11, 2036in 9 yr 11 mo
U-1719
10537642Apr 11, 2036in 9 yr 11 mo
U-1719
10369224Apr 11, 2036in 9 yr 11 mo
U-4134
10532101Apr 11, 2036in 9 yr 11 mo
U-1719
11285213Apr 11, 2036in 9 yr 11 mo
U-1719
10426839Apr 11, 2036in 9 yr 11 mo
U-4135
10471014Apr 11, 2036in 9 yr 11 mo
U-1719
11219626Apr 11, 2036in 9 yr 11 mo
U-1719
10471069Apr 11, 2036in 9 yr 11 mo
U-1719
10512692Apr 11, 2036in 9 yr 11 mo
U-1719
11207328Apr 11, 2036in 9 yr 11 mo
U-1719
10512693Apr 11, 2036in 9 yr 11 mo
U-1719
11135295Apr 11, 2036in 9 yr 11 mo
U-1719
11045549Apr 11, 2036in 9 yr 11 mo
U-1719
11020483Apr 11, 2036in 9 yr 11 mo
U-1719
11826370Apr 11, 2036in 9 yr 11 mo
U-1719
10940153Apr 11, 2036in 9 yr 11 mo
U-1719
11602563Apr 11, 2036in 9 yr 11 mo
U-1719
11806354Apr 11, 2036in 9 yr 11 mo
U-1719
11510927Apr 11, 2036in 9 yr 11 mo
U-1719
10933137Apr 11, 2036in 9 yr 11 mo
U-1719
11504429Apr 11, 2036in 9 yr 11 mo
U-1719
11471464Apr 11, 2036in 9 yr 11 mo
U-1719
10933136Apr 11, 2036in 9 yr 11 mo
U-1719
11801250Apr 11, 2036in 9 yr 11 mo
U-1719
10799588Apr 11, 2036in 9 yr 11 mo
U-1719
10780165Apr 11, 2036in 9 yr 11 mo
U-1719
10821181Apr 11, 2036in 9 yr 11 mo
U-1719
11759522Apr 11, 2036in 9 yr 11 mo
U-1719
10758618Apr 11, 2036in 9 yr 11 mo
U-1719
10918722Apr 11, 2036in 9 yr 11 mo
U-1719
11738085Apr 11, 2036in 9 yr 11 mo
U-1719
11013805Apr 11, 2036in 9 yr 11 mo
U-1719
11712441Apr 11, 2036in 9 yr 11 mo
U-1719
10905693Apr 11, 2036in 9 yr 11 mo
U-1719
11628173Apr 11, 2036in 9 yr 11 mo
U-1719
10894053Apr 11, 2036in 9 yr 11 mo
U-1719
11617791Apr 11, 2036in 9 yr 11 mo
U-1719
10821182Apr 11, 2036in 9 yr 11 mo
U-1719
11617756Apr 11, 2036in 9 yr 11 mo
U-1719
11607456Apr 11, 2036in 9 yr 11 mo
U-1719
11571428Apr 11, 2036in 9 yr 11 mo
U-1719
11471465Apr 11, 2036in 9 yr 11 mo
U-1719
10780166Apr 11, 2036in 9 yr 11 mo
U-1719
10758617Apr 11, 2036in 9 yr 11 mo
U-1719
12485176Apr 11, 2036in 9 yr 11 mo
U-4133
10265400Apr 11, 2036in 9 yr 11 mo
U-4509
10265399Apr 11, 2036in 9 yr 11 mo
U-4509
10307484Apr 11, 2036in 9 yr 11 mo
U-4509
10369225Apr 11, 2036in 9 yr 11 mo
U-4356
10456471Apr 11, 2036in 9 yr 11 mo
U-4509
11266657Apr 11, 2036in 9 yr 11 mo
U-1719
11433078Apr 11, 2036in 9 yr 11 mo
U-1719
11433079Apr 11, 2036in 9 yr 11 mo
U-1719
11944683Apr 11, 2036in 9 yr 11 mo
U-1719
10058614Apr 11, 2036in 9 yr 11 mo
Product
10463736Apr 11, 2036in 9 yr 11 mo
Product
12472257May 18, 2038in 12 yr 1 mo
U-4134
12472256May 18, 2038in 12 yr 1 mo
U-4356
12616752May 18, 2038in 12 yr 1 mo
U-4510
12472258May 18, 2038in 12 yr 1 mo
Product
12551489May 28, 2040in 14 yr 2 mo
U-1719
12551488May 28, 2040in 14 yr 2 mo
U-1719
12128052May 28, 2040in 14 yr 2 mo
U-1719
12370196Dec 29, 2041in 15 yr 9 mo
U-1719
12611413Dec 29, 2041in 15 yr 9 mo
U-1719
12005118Jan 25, 2043in 16 yr 10 mo
U-1719
12544383Mar 10, 2045in 19 yr
U-1719

Meloxicam; rizatriptan benzoate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.